From July 10-11 AmCham China’s Healthcare Industry Group led a delegation of member company representatives on a visit to Hefei in Anhui province. During the two day visit, the Chamber, together with the Anhui Provincial Council for the Promotion of International Trade, organized a series of discussions and events on the multinational healthcare industry corporations’ cooperation and exchange.
Anhui Province has been striving to build a leading domestic modern pharmaceutical industry system. After years of development, Anhui Province has formed an industrial system in which raw materials and chemical drugs, traditional Chinese medicine, and its production serve as the foundation, while biological drugs and medical devices are cultivated, and cell and gene therapy, as well as medical artificial intelligence, are positioned as part of a key strategic layout for the future. The pharmaceutical distribution and outsourcing services work in synergy with the bio-pharmaceutical industry system, which has initially formed industrial clustering in cities such as Hefei, Fuyang, and Bozhou. Nine multinational healthcare companies in China participated in this trip, including Boston Scientific, Danaher, AbbVie, Roche Diagnostics, CNNC Accuray, Becton Dickinson, DiaSorin, Bayer, and Johnson & Johnson.
July 10 (Morning) AmCham China Policy Exchange Conference with Anhui Healthcare Security Administration: AmCham China held a discussion and exchange meeting with the Anhui Provincial Healthcare Security Administration. The meeting was jointly organized by the AmCham Healthcare Industry Group and the Anhui Provincial Council for the Promotion of International Trade. Representatives from the relevant departments of the Anhui Provincial Healthcare Security Administration were invited to attend the meeting, and the meeting was chaired by Director Zheng Dong Tao from the Anhui Provincial Council for the Promotion of International Trade (Anhui Provincial CCPIT).
During the meeting, representatives from both the government and the companies had in-depth discussions on topics such as medical reform in Anhui Province, medical insurance catalogs, and reimbursement policies. Vice President Claire Ma briefly introduced AmCham China and expressed gratitude to the Anhui Provincial CCPIT for organizing and assisting with the meeting, as well as to the Anhui Provincial Healthcare Security Administration for their strong support. Subsequently, the “2023 American Business in China Healthcare Industry White Paper” was presented to the Anhui Provincial Healthcare Security Administration. AmCham China believes that this dialogue will effectively help numerous global companies in China to understand Anhui Province’s medical insurance policies and development opportunities and promote the better integration of business into China’s economic and social development.
July 10 (Morning) AmCham China Healthcare Industry Group visited the Biopharmaceutical industries of Shushan District: Led by Director Zheng Dong Tao from the Anhui Provincial CCPIT, President Michael Hart from AmCham China, along with representatives from attending companies, visited several locations including the Hefei Cancer Hospital of the Chinese Academy of Sciences in Shushan, Heyuan Pharmaceutical Co., Ltd., and the Keliqike Innovation Station (Science Island Station).
By visiting hospitals, pharmaceutical companies, and research institutions in the park, the representatives of the visiting companies gained an understanding of the overall development and industrial advantages of the biopharmaceutical industry in Shushan, Hefei. At the same time, the company representatives introduced their respective business operations and expressed their intentions for future investments in China. AmCham China will continue to follow up on the industrial docking between the visiting companies and the park and facilitate further cooperation opportunities.
July 10 (Afternoon), Governor Qing Xian Wang met with AmCham President Michael Hart, with Vice Governor Xiang Qian Shan in attendance: Representatives from nine global healthcare companies attended this meeting to discuss business cooperation in Anhui Province. Governor Wang Qing Xian pointed out that with China’s comprehensive opening-up environment, Anhui Province has leveraged its unique advantages in location, scientific innovation, and industries to develop emerging industries such as biopharmaceuticals. Anhui has become a new frontier for reform and opening up that attracts global investors’ attention. AmCham President Michael Hart and the company representatives expressed their high regard for Anhui’s development prospects. AmCham China will work together with its member companies to further engage with Anhui and promote exchanges and cooperation in various fields, including biopharmaceuticals, to better serve the Chinese market.
July 11 (Morning), AmCham China Healthcare Industry Group conducted a business inspection in the Hefei High-tech Industrial Development Zone: Led by Deputy Director Xiao Fan Wang from the Anhui Provincial CCPIT, Vice President Claire Ma from AmCham China, along with representatives from attending companies, visited two biopharmaceutical companies located in the Hefei High-tech Zone: Ankebio and Anhui ZFSW Biologics Company.
The attending companies learned that both biopharmaceutical companies have been developing rapidly with active policy support in the high-tech zone. Moreover, the attending companies were also impressed by the favorable investment environment and the open government cooperation attitude in the zone. The company representatives expressed great intention to consider the advantages of the Hefei High-tech Zone and explore opportunities for cooperation in their future business development in China.
July 11 (Afternoon), AmCham China held a discussion and exchange meeting with the Anhui Provincial Health Commission, relevant government units, and the Anhui Provincial Medical Products Administration: The meeting was jointly organized by AmCham China Healthcare Industry Group and the Anhui Provincial CCPIT. Representatives from the Anhui Provincial Health Commission, relevant government units, and the Anhui Provincial Medical Products Administration were invited to attend the second half of the meeting, which was hosted by Deputy Director Wang Xiao Fan from the Anhui Provincial CCPIT.
During the meeting, the representatives had professional and productive interactions on topics such as the construction of public medical services, the evaluation and approval process for drugs and medical devices, and outbound training for physicians. AmCham Vice President Claire Ma expressed gratitude to the Anhui Provincial CCPIT for organizing the meeting and to the Anhui Provincial Health Commission and the Anhui Provincial Medical Products Administration for their strong support for the meeting. Subsequently, the “2023 American Business in China Healthcare Industry White Paper” was presented to the attending government departments.